Position in QGEN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$6,410,444
+$4,265,804 QoQ
Shares Held
160,101
+233.5% QoQ
Ownership
0.078%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in QGEN Over Time
Shares Held
Position Value (USD)
Derivatives in QGEN
reported options exposure · as of Mar 31, 2026CallValue
$8,164,156
CallShares
203,900
PutValue
$3,723,720
PutShares
93,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Caption Management, LLC holds $5,547,975 across 3 Diagnostics & Research names.
All Filings in QGEN
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,723,720 | 93,000 | Put | Sole | 2026-05-15 | |
| 2026-03-31 | $6,410,444 | 160,101 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $8,164,156 | 203,900 | Call | Sole | 2026-05-15 | |
| 2025-09-30 | $2,144,640 | 48,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,979,720 | 62,000 | Call | Sole | 2025-08-14 | |
| 2022-03-31 | $3,084 | 61 | Shares | Sole | 2022-05-13 | |
| 2022-03-31 | $1,294,530 | 25,600 | Call | Sole | 2022-05-13 | |
| 2021-12-31 | $5,598,150 | 97,600 | Call | Sole | 2022-02-11 | |
| 2021-09-30 | $5,205,330 | 97,600 | Call | Sole | 2021-11-12 | |
| 2021-06-30 | $8,367,899 | 167,600 | Call | Sole | 2021-08-16 | |
| 2021-03-31 | $11,290,658 | 224,700 | Call | Sole | 2021-05-17 | |
| 2020-12-31 | $1,284,326 | 23,548 | Shares | Sole | 2021-02-16 | |
| 2020-12-31 | $7,908,416 | 145,000 | Call | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||